Literature DB >> 2292350

Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients.

D Taranto1, R Suozzo, I de Sio, M Romano, N Caporaso, C Del Vecchio Blanco, M Coltorti.   

Abstract

This study was undertaken to evaluate the effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Sixteen cirrhotics were randomly assigned to metoclopramide (10 mg i.v.) or saline. Metoclopramide significantly decreased transmural variceal pressure (15.7% decrease, p less than 0.05 vs. basal value). In order to evaluate if the metoclopramide-induced drop in transmural variceal pressure was due to an effect on portal haemodynamics, we also measured, by means of real time and pulsed Doppler ultrasonography, portal vein diameter, mean velocity of portal flow, and portal venous flow. No significant change was observed before and after metoclopramide. In conclusion, metoclopramide, which increases lower oesophageal sphincter pressure, significantly decreases transmural variceal pressure in cirrhotic patients. However, it does not have any effect on portal haemodynamics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292350     DOI: 10.1159/000200477

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  7 in total

Review 1.  Portal hypertension management.

Authors:  J Terblanche
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

Review 2.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  Metoclopramide inhibits development of esophageal varices in rat model.

Authors:  M Ohta; M Hashizume; K Tanoue; K Ueno; K Komori; T Ishii; S Kitano; K Sugimachi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

4.  Effects of octreotide on lower esophageal sphincter in patients with cirrhosis and portal hypertension.

Authors:  T Barrioz; C Borderie; P Strock; P Ingrand; E Fort; C Silvain; M Beauchant
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

5.  Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.

Authors:  Edward J Wu; Dennis J Goussetis; Elspeth Beauchamp; Ewa M Kosciuczuk; Jessica K Altman; Elizabeth A Eklund; Leonidas C Platanias
Journal:  Cancer Biol Ther       Date:  2014-02-04       Impact factor: 4.742

6.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

7.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.